Biovail announce plans to shed sales organization jobs

Share this article:
Canadian drugmaker Biovail announced plans to shed its US-based sales organization and related jobs in an effort to cut costs as it readies for challenges to the patent on Wellbutrin XL. The job cuts call for the elimination of 200 positions, the firm said. Biovail plans to eliminate its US specialty sales force and related support functions.

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...